Home
Contact Us
About Us
Advertise
Biotech
Finance
Tech News
Disclaimer
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
BioPharmaJournal
Home
Contact Us
About Us
Advertise
Biotech
Applied Therapeutics Surges on Positive FDA Update for Govorestat
Portage Biotech (PRTG): Wild Ride Continues, But Uncertainty Looms
Pfizer’s (NYSE: PFE) Ponsegromab Shows Promise in Fighting Cancer Cachexia
Singular Genomics (OMIC) Receives Buyout Offer, Stock Soars
Instil Bio (TIL) Surges on Promising Cancer Therapy Licensing Deal
Finance
Aligos Therapeutics ($ALGS): A Bold Move to Regain Nasdaq Compliance
Portage Biotech Inc. (NASDAQ: PRTG): A Closer Look at a Tumultuous…
Avalon GloboCare (ALBT) surges post Launch of Innovative Male Incontinence Device
Reason why Inspirato Incorporated (ISPO) has high trading volume today
Clearmind Medicine Inc (CMND) briefly surges and here’s why
Tech News
Aehr Test Systems (NASDAQ: AEHR) Receives an Order of $10.8 Million…
Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…
Micro and Macro Tailwinds Converge for KULR
ISWH and the Rebirth of the Crypto Cycle
Disclaimer
Home
Tags
Curis Inc. (NASDAQ: CRIS)
Tag: Curis Inc. (NASDAQ: CRIS)
Curis Inc. (NASDAQ: CRIS) Expands Executive Leadership With Addition Of Three...
Gavins Felicity
-
January 13, 2022
0
Curis Inc. (NASDAQ: CRIS) Doses First Subject in The Combination Therapy...
Kate Hudson
-
November 19, 2021
0
Recent Post
Applied Therapeutics Surges on Positive FDA Update for Govorestat
Kate Hudson
-
September 18, 2024
0
Applied Therapeutics (APLT) saw its stock price jump over 68% on September 18th, 2024, following a positive update on the regulatory pathway...
Portage Biotech (PRTG): Wild Ride Continues, But Uncertainty Looms
September 18, 2024
Pfizer’s (NYSE: PFE) Ponsegromab Shows Promise in Fighting Cancer Cachexia
September 15, 2024
Singular Genomics (OMIC) Receives Buyout Offer, Stock Soars
September 15, 2024
Instil Bio (TIL) Surges on Promising Cancer Therapy Licensing Deal
September 12, 2024
